Literature DB >> 34806027

Dissociable effects of APOE-ε4 and β-amyloid pathology on visual working memory.

Kirsty Lu1, Jennifer M Nicholas2, Yoni Pertzov3, John Grogan4, Masud Husain4,5, Ivanna M Pavisic1,6, Sarah-Naomi James6, Thomas D Parker1, Christopher A Lane1, Ashvini Keshavan1, Sarah E Keuss1, Sarah M Buchanan1, Heidi Murray-Smith1, David M Cash1,7, Ian B Malone1, Carole H Sudre1,6,8,9, William Coath1, Andrew Wong6, Susie M D Henley1, Nick C Fox1,7, Marcus Richards6, Jonathan M Schott1, Sebastian J Crutch1.   

Abstract

Although APOE-ε4 carriers are at significantly higher risk of developing Alzheimer's disease than non-carriers1, controversial evidence suggests that APOE-ε4 might confer some advantages, explaining the survival of this gene (antagonistic pleiotropy)2,3. In a population-based cohort born in one week in 1946 (assessed aged 69-71), we assessed differential effects of APOE-ε4 and β-amyloid pathology (quantified using 18F-Florbetapir-PET) on visual working memory (object-location binding). In 398 cognitively normal participants, APOE-ε4 and β-amyloid had opposing effects on object identification, predicting better and poorer recall respectively. ε4-carriers also recalled locations more precisely, with a greater advantage at higher β-amyloid burden. These results provide evidence of superior visual working memory in ε4-carriers, showing that some benefits of this genotype are demonstrable in older age, even in the preclinical stages of Alzheimer's disease.

Entities:  

Year:  2021        PMID: 34806027      PMCID: PMC7612005          DOI: 10.1038/s43587-021-00117-4

Source DB:  PubMed          Journal:  Nat Aging        ISSN: 2662-8465


  57 in total

1.  APOE moderates compensatory recruitment of neuronal resources during working memory processing in healthy older adults.

Authors:  Elisa Scheller; Jessica Peter; Lena V Schumacher; Jacob Lahr; Irina Mader; Christoph P Kaller; Stefan Klöppel
Journal:  Neurobiol Aging       Date:  2017-04-26       Impact factor: 4.673

2.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Ronald C Petersen; Michael W Weiner; Paul S Aisen; Leslie M Shaw; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Vernon S Pankratz; Michael C Donohue; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2013-02       Impact factor: 44.182

3.  Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers.

Authors:  Natalie L Marchant; Sarah L King; Naji Tabet; Jennifer M Rusted
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

4.  Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Authors:  Victor L Villemagne; Samantha Burnham; Pierrick Bourgeat; Belinda Brown; Kathryn A Ellis; Olivier Salvado; Cassandra Szoeke; S Lance Macaulay; Ralph Martins; Paul Maruff; David Ames; Christopher C Rowe; Colin L Masters
Journal:  Lancet Neurol       Date:  2013-03-08       Impact factor: 44.182

Review 5.  Does apolipoprotein E genotype influence cognition in middle-aged individuals?

Authors:  Gerardo Salvato
Journal:  Curr Opin Neurol       Date:  2015-12       Impact factor: 5.710

6.  Working memory recall precision is a more sensitive index than span.

Authors:  Nahid Zokaei; Stephanie Burnett Heyes; Nikos Gorgoraptis; Sanjay Budhdeo; Masud Husain
Journal:  J Neuropsychol       Date:  2014-09-11       Impact factor: 2.864

7.  Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development.

Authors:  Christopher A Lane; Thomas D Parker; Dave M Cash; Kirsty Macpherson; Elizabeth Donnachie; Heidi Murray-Smith; Anna Barnes; Suzie Barker; Daniel G Beasley; Jose Bras; David Brown; Ninon Burgos; Michelle Byford; M Jorge Cardoso; Ana Carvalho; Jessica Collins; Enrico De Vita; John C Dickson; Norah Epie; Miklos Espak; Susie M D Henley; Chandrashekar Hoskote; Michael Hutel; Jana Klimova; Ian B Malone; Pawel Markiewicz; Andrew Melbourne; Marc Modat; Anette Schrag; Sachit Shah; Nikhil Sharma; Carole H Sudre; David L Thomas; Andrew Wong; Hui Zhang; John Hardy; Henrik Zetterberg; Sebastien Ourselin; Sebastian J Crutch; Diana Kuh; Marcus Richards; Nick C Fox; Jonathan M Schott
Journal:  BMC Neurol       Date:  2017-04-18       Impact factor: 2.474

Review 8.  The Genetic Variability of APOE in Different Human Populations and Its Implications for Longevity.

Authors:  Paolo Abondio; Marco Sazzini; Paolo Garagnani; Alessio Boattini; Daniela Monti; Claudio Franceschi; Donata Luiselli; Cristina Giuliani
Journal:  Genes (Basel)       Date:  2019-03-15       Impact factor: 4.096

Review 9.  Antagonistic Pleiotropy in Human Disease.

Authors:  Sean G Byars; Konstantinos Voskarides
Journal:  J Mol Evol       Date:  2019-12-21       Impact factor: 3.973

10.  Dissociable effects of the apolipoprotein-E (APOE) gene on short- and long-term memories.

Authors:  Nahid Zokaei; Giedrė Čepukaitytė; Alexander G Board; Clare E Mackay; Masud Husain; Anna Christina Nobre
Journal:  Neurobiol Aging       Date:  2018-09-25       Impact factor: 4.673

View more
  3 in total

1.  Inter- and intra-chromosomal modulators of the APOE ɛ2 and ɛ4 effects on the Alzheimer's disease risk.

Authors:  Alireza Nazarian; Ian Philipp; Irina Culminskaya; Liang He; Alexander M Kulminski
Journal:  Geroscience       Date:  2022-07-09       Impact factor: 7.713

2.  Contributions of sex and genotype to exploratory behavior differences in an aged humanized APOE mouse model of late-onset Alzheimer's disease.

Authors:  John W McLean; Avnish Bhattrai; Francesca Vitali; Adam C Raikes; Jean-Paul L Wiegand; Roberta Diaz Brinton
Journal:  Learn Mem       Date:  2022-09-02       Impact factor: 2.699

Review 3.  Mitochondria-Microbiota Interaction in Neurodegeneration.

Authors:  Peter Kramer
Journal:  Front Aging Neurosci       Date:  2021-12-23       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.